©2012 Baishideng.
World J Gastrointest Pharmacol Ther. Apr 6, 2012; 3(2): 7-20
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Published online Apr 6, 2012. doi: 10.4292/wjgpt.v3.i2.7
Table 1 Non-genetic risk factors for gallbladder stones
| Age |
| Female gender |
| High-calorie, low-fiber diet |
| High-carbohydrate diet, dietary glycemic load |
| Obesity |
| Physical inactivity |
| Rapid weight loss/surgery for obesity |
| Total gastrectomy with lymph node dissection |
| Spinal cord injury |
| Infections: enterohepatic Helicobacter species, malaria |
| Biliary strictures |
| Drugs: estrogens, calcineurin inhibitors, fibrates, octreotide, ceftriaxone |
| Total parenteral nutrition |
| Duodenal diverticulum |
| Extended ileal resection (black pigment stones) |
| Vitamin B12/folic acid deficient diet (black pigment stones) |
| Pancreatic insufficiency |
| Cholangitis (brown pigment bile duct stones) |
- Citation: Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: What it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012; 3(2): 7-20
- URL: https://www.wjgnet.com/2150-5349/full/v3/i2/7.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i2.7